KBC Group’s Phibro Animal Health PAHC Stock Holding History

KBC Group’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$29K	Buy	+519	New	+$24.7K	﹤0.01%	1802
2023 Q3	–	Sell	-1,572	Closed	-$22K	–	1944
2023 Q2	$22K	Hold	1,572	–	–	﹤0.01%	1464
2023 Q1	$24K	Hold	1,572	–	–	﹤0.01%	1481
2022 Q4	$21K	Hold	1,572	–	–	﹤0.01%	1502
2022 Q3	$21K	Hold	1,572	–	–	﹤0.01%	1511
2022 Q2	$30K	Buy	+1,572	New	+$29.8K	﹤0.01%	1496
2019 Q1	–	Sell	-4,379	Closed	-$141K	–	1430
2018 Q4	$141K	Sell	4,379 -11,683	-73%	-$441K	﹤0.01%	1160
2018 Q3	$689K	Buy	+16,062	New	+$759K	0.01%	1026
2017 Q4	–	Sell	-4,478	Closed	-$166K	–	1284
2017 Q3	$166K	Hold	4,478	–	–	﹤0.01%	1142
2017 Q2	$166K	Buy	+4,478	New	+$146K	﹤0.01%	1130

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

KBC Group's PAHC Position: Q1 2026 in Review

KBC Group opened a new position in Phibro Animal Health (PAHC) in Q1 2026: 519 shares worth $29K. The stake represents ﹤0.01% of the portfolio and ranks #1802 among its holdings. This is a return to the name: KBC Group previously reported a position in PAHC as recently as Q2 2023.

KBC Group first reported a position in PAHC in Q2 2017 and has held it in 10 quarters since. The position peaked at $689K in Q3 2018. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

KBC Group held 519 shares of Phibro Animal Health worth $29K as of Q1 2026.
Phibro Animal Health was a new KBC Group position in Q1 2026.
Phibro Animal Health made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #1802 holding.
KBC Group first reported a position in Phibro Animal Health in Q2 2017 and has held it in 10 quarters since.
KBC Group's Phibro Animal Health position peaked at $689K in Q3 2018.
257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.